Govt funds neurostimulation for major depression
Thousands of patients refractory to drugs will benefit, psychiatrists say
Patients with treatment-resistant depression will no longer have to pay thousands of dollars for a last-resort therapy following the success of a long-running campaign for Medicare funding.
From November, the Federal Government will fund four Medicare items to provide access to repetitive transcranial magnetic stimulation (rTMS) for an estimated 90,000 adult patients with major depressive disorder over the next four years.
